Gagnon Gilles 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Oct 11, 2018
Insider Transaction Report
Form 4
Gagnon Gilles
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-10-09$15.33/sh−10,000$153,349→ 72,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.